Navigation Links
Emerging staph strains found to be increasingly deadly and deceptive

he ability of S. aureus to evade and destroy neutrophils, their work could lead to new medical treatments.

"Each day physicians around the world are stymied by the inability to effectively treat patients suffering from severe S. aureus infections," says NIAID Director Anthony S. Fauci, M.D. "There is a critical need to develop new treatments against late-stage disease caused by antibiotic-resistant strains, and this promising work offers several new approaches."

According to the Centers for Disease Control and Prevention, "recent reports of 'community-acquired' MRSA infections raise concern ?If MRSA becomes the most common form of Staphylococcus aureus in a community, it will make treatment of common infections much more difficult." The April 7, 2005, issue of The New England Journal of Medicine refers in an editorial to "?an epidemic of MRSA in the community."

S. aureus strains acquired in health-care settings can be challenging to resolve because of antibiotic resistance, which limits the choices for treatment. But the situation can become more serious with the newer community-acquired strains, says Dr. DeLeo. "We do not know why cases of community-acquired MRSA infections are increasing, let alone how they flourish," he says. But scientists do know the community strains can cause more severe forms of disease.

Mild S. aureus infections such as impetigo, which typically forms small blisters on the faces of children, or cellulitis, an inflammation of skin or muscle tissue, can easily be treated and usually resolve in a matter of days. But S. aureus disease also can be much more severe and difficult to treat, affecting vital organs and leading to toxins poisoning the blood and infection overwhelming the heart. One of the most severe types of disease is necrotizing pneumonia, where bacteria destroy lung tissue.

"The reason that some mild infections become severe or fatal is not well understood, but virulence is often associated
'"/>

Source:NIH/National Institute of Allergy and Infectious Diseases


Page: 1 2 3

Related biology news :

1. Ticks, flukes, and genomics: Emerging pathogens revealed
2. Substance protects resilient staph bacteria
3. Study indicates dramatic rise in antibiotic-resistant community-acquired staph infections
4. Less virulent strains of avian influenza can infect humans
5. Study outlines genetic differences between potential pandemic influenza strains
6. Human behavior changes the number of strains of infectious diseases
7. Experimental vaccine protects lab animals against several strains of H5N1
8. Complexity constrains evolution of human brain genes
9. New test for most virulent HPV strains under study
10. New component of the brakes on nerve regeneration found
11. Strongest proof yet found for prion hypothesis

Post Your Comments:
(Date:11/4/2009)...ral science) , United States Using Less Water ... than it did 35 years ago, despite a 30 percent po...y attributable to alternative cooling methods at p... According to the latest USGS water use report, ne...oes to cooling thermoelectric power plants. Irriga...
(Date:11/4/2009)...at Norman has received more than $10 million in re...f the federal stimulus program, bringing thetotal ...ers to $23 million. Thirty-three projects achieve...ology to weather. , "The university has thoughtf...areasof scholarly excellence to federal agency pri...
(Date:11/4/2009)...RNewswire/ -- What,s the cost of saving a teenage ... resulting from prescription medication abuse, the...owever, may be unaware that the lock-boxes they,ve... ticking timebomb of prescription drugs. That,s wh... medical supplies, has formed an exclusive partner...
Breaking Biology News(10 mins):USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City 13311 1Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City 13311 2Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 53371 1Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 53371 2Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 53371 3House Committee Approves Amendment Eliminating Cost Sharing for Medicaid Preventive Services 53367 1House Committee Approves Amendment Eliminating Cost Sharing for Medicaid Preventive Services 53367 2
...F) is a chronic lung disease typically characteriz...of breath or cough. Most patients live about five ... study being published today in the online journal...netic profile has a much more rapid progression to...ng transplant. , Based on observations in the clin...
...to watching out for other mothers, kids. , An in...ducted by the University of Alberta in Edmonton, C...nada, showed that both species responded to the re...ponses elicited when coyotes attack fawns, with mu...ule deer calls, even when their own fawn stood nex...
...ery effective method for revealing anatomical deta...ake these images even clearer and allow physiologi...ional gadolinium complexes currently used as MRI c...s reported in the journal Angewandte Chemie, Korea...al Center and Taeghwan Hyeon at Seoul National Uni...
Other Biology News:Gene expression patterns predict rapid decline in idiopathic pulmonary fibrosis patients 2Mule deer moms rescue other fawns 2
(Date:11/6/2009)..., LYNBROOK, N.Y., Nov. 6 /PRNewswire-FirstCall/ ...), a biopharmaceutical company developing first-in... its financial results for the third quarter ended...py that, in September of this year, the FDA,s Arth...by a vote of 12-0, the approval of XIAFLEX(TM) for...
(Date:11/6/2009)..., SPRING VALLEY, Calif., Nov. 6 ...awarded a Small Business Innovative Research (SBIR...ch and Material command. Under terms of the agreem...ents (ASRs) for the diagnosis of Dengue virus. ...hat represents a major threat to military forces d...
(Date:11/5/2009)..., GAITHERSBURG, Md., Nov. 5 /PRNewswire-FirstCal...d its financial results for the third quarter ende...f $3.6 million ($0.04 per share) for the three mon...s of $6.8 million ($0.08 per share) in the compara...tember 30, 2009, GenVec,s net loss was $14.1 milli...
(Date:11/5/2009)..., Conference Call on Thursday, November 5, 2009 ...ANCOUVER Nov. 5 /PRNewswire-FirstCall/ - OncoGenex...y") (NASDAQ: OGXI ) today reported unaudited fina...s ended September 30, 2009 and reviewed the Compan..., The following consolidated results reflect the o...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...1 Neogen Corporation,(Nasdaq: NEOG ) announced t...nimal health and hygiene applications from DuPont ... includes 14 different product formulations,along ... registration,information. The purchase price and ...products to Neogen,s Animal Safety group adds to,t...
...1 ChromaDex, Inc. ("ChromaDex"),today announced t...er with,CDI Acquisition, Inc. ("CDI"), the wholly-...(OTC Bulletin Board: CDYE). The transaction,enable...shares are publicly,traded, which will help it be ...apidly growing marketplace. The business and opera...
...on Available to Discuss UWB Real-Time Location Sys...AMA Report, HUNTSVILLE, Ala., July 1 Time Domain...dnesday, June 25, the Journal of the American Medi...that radio frequency identification,(RFID) may dis...quipment,and occasionally induce "potentially" haz...
Other Biology Technology:Neogen Acquires Product Line From DuPont Animal Health Solutions 2ChromaDex, Inc. Announces Completion of Reverse Merger With Cody Resources, Inc. 2
...sents the state-of-the-art in permanent mounting m...n of immunohistochemical organic insoluble substra...Fuchsin, and any other organic solvent compatible ...n be used for histology and cytology applications ...
pLivSelect PCR Cloning Kit R from Bio S&T
...Express is the first fully automated proteomics wo...fer operations with complete data tracking. It aut...colony picking through final protein expression an...le of delivering a plate to any of its instruments...
OLIGO from Molecular Biology Insights
Biology Products: